Olanzapine for delirium in parkinsonism: therapeutic benefits in lieu of adverse consequences.
N
N
Gupta
Parveen
P
Sharma
S
S
Prabhakar
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D003693:Delirium / Q000188:drug therapy* / Q000209:etiology*; D005260:Female; D006801:Humans; D000077152:Olanzapine; D020734:Parkinsonian Disorders / Q000523:psychology*
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine